Get Latest Update About Chronic Lymphocytic Leukemia on Webcast

OSU Wexner Medical Center logo

Get Latest Update About Chronic Lymphocytic Leukemia on Webcast.  This webcast will discuss Chronic Lymphocytic Leukemia. This presentation will first discuss the approach and diagnosis to lymphocytosis. It will use case presentations to highlight the presentation and evaluation of chronic lymphocytic leukemia (CLL). The presenter will also review complications and health maintenance implications for CLL. The second half of the talk will discuss staging and risk stratification. The presenter will review the rationale for observation and indications for treatment as well as the various different treatment options and their associated side effects.

Patients with CLL can have nonspecific symptoms like fatigue and lymphadenopathy—or be entirely asymptomatic. As a result, many cases of CLL are first detected incidentally through routine bloodwork showing lymphocytosis. Unlike many cancers, CLL often progresses so slowly that some patients may not need treatment. Others may not be so lucky and suffer devastating complications such as cytopenias, infections, and secondary malignancies. On this webcast, we’ve invited two Ohio State University’s Hematology experts who both specialize in CLL to discuss this common subtype of Leukemia. How do we diagnose it? And how do we manage it? We’re pleased to introduce Assistant Professor of Hematology Dr. Aseel Alsouqi. Aseel treats not only patients with CLL but also non-Hodgkin’s lymphoma and is an investigator on several clinical trials for leukemia and lymphoma. We also have Associate Professor of Hematology Dr. Seema Bhat. In addition to her clinical treating of patients with CLL, Seema is also a principal investigator on clinical trials for novel CLL therapies.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Learn the basic diagnostic work up for CLL
  • Understand the health implications of CLL
  • Understanding Staging and Risk Stratification of CLL
  • Understand rationale of observation for early-stage asymptomatic patients with CLL and approach to select treatment for CLL when indicated.

You’ll also learn about the following:

  • Prognosis
  • Evolution of CLL
  • PCP’s role
  • Therapies
  • CLL Patients in the Hospital

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Common Poisonings and Toxidromes

OSU Wexner Medical Center logo

CME Webcast Teaches on Common Poisonings and Toxidromes.  In this session, learners will review the epidemiology of poisonings across the lifespan, with an emphasis on recent trends. We will introduce a practical framework for evaluating the poisoned patient and review common toxidromes relevant to clinical practice. Participants will develop their skills in recognizing key signs of toxicity to initiate timely, evidence-based management.

Today’s toxicological landscape reflects our modern world and while natural toxins persist, synthetic drugs, household chemicals, and pharmaceutical overdoses dominate emergency department presentations.

For this program on common poisonings and toxidromes, we’ve invited an Emergency Medicine expert. Dr Christopher Gaw is an Assistant Professor of Pediatric Emergency at Nationwide Children’s Hospital. In addition to his clinical work, he is also an injury prevention researcher with expertise in toxicology and public health.

What you’ll learn on this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe the epidemiology of poisonings over the lifespan
  • Review and apply a clinical framework with which to approach the poisoned patient

You’ll also learn about the following:

  • Setting of Care
  • Vitamins & Supplements
  • Gastric Lavage
  • Prevention

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series

OSU Wexner Medical Center logo

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series.  Participants will gain an understanding of evidence-based strategies to support patients in quitting tobacco including behavioral interventions and pharmacotherapy options. Actuarily, on average, a woman who smokes a pack of cigarettes a day will live 11 years less than a woman who doesn’t smoke. Men who smoke a pack a day live 12 years less than non-smoking men. If you do the math, that works out to 14 minutes of life lost for every cigarette a person smokes. It’s a childhood epidemic with 90% of smokers beginning before age 18. By the time they are adults, they are fully addicted and quitting becomes very hard because of the severity of nicotine withdrawal symptoms.   But the good news is that we can help ameliorate those symptoms to help patients quit their nicotine habits.

Joining us today are two of the Ohio State University’s tobacco cessation experts. Lindsey Lee is a clinical pharmacist in the Division of General Internal Medicine. And Suzanne Higginbotham is also a clinical pharmacist in the Division of General Internal Medicine.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the health impacts of tobacco use
  • Apply evidence-based cessation strategies and interventions for nicotine dependence
  • Implement appropriate treatment and follow up protocols to enhance patient adherence and reduce relapse

You’ll also learn about the following:

  • Nicotine dependence tests
  • The pharmacist’s role in tobacco cessation
  • Nicotine replacement strategies for the heavy smoker
  • Cytisinicline (cytisine)
  • Pharmacologic approach to inpatients who are smokers
  • Pharmacologic approach to the smoker with coronary artery disease
  • Tobacco cessation and adolescents
  • Weight gain and tobacco cessation
  • E-cigarettes and tobacco cessation
  • Cough increase in the short-term after smoking cessation
  • Tobacco cessation in the habitual marijuana smoker
  • Over the counter pharmacologic therapies
  • Pharmacist prescriptive authority

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Get Latest Update on Measles on CME Webcast

OSU Wexner Medical Center logo

Get Latest Update on Measles on CME Webcast.  This presentation will review the pathophysiology, clinical presentation, diagnosis, management, and prevention of measles virus infection. Common questions encountered in the outpatient clinic will also be discussed.

For this special program, we’ve brought in a Pediatric Infectious Disease & Epidemiology expert Dr. Matthew Washam.  Dr Washam is the Medical Director of Infection Prevention and Control at Nationwide Children’s Hospital and has presented and published nationwide about the 2022 Columbus Measles outbreak.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Identify the clinical features and complications of measles, such as prodromal symptoms and the characteristic rash phase
  • Describe the diagnostic methods, current management strategies, and preventive measures to control outbreaks

You’ll also learn about the following:

  • Vaccine Efficacy
  • Early Vaccination

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Learners About Alzheimer’s Disease

OSU Wexner Medical Center logo

CME Webcast Teaches Learners About Alzheimer’s Disease.  Expert Teaches on Artificial Intelligence in Medicine. This program will discuss Alzheimer’s Disease.  This webcast will discuss new developments in our understanding of the pathogenesis and diagnosis of Alzheimer’s Disease. In addition, this webcast will review new treatments for Alzheimer’s Disease, including anti-amyloid monoclonal antibodies.

For more than a century, there was little physicians could do for patients with Alzheimer’s Disease other than diagnose it and provide supportive care. But during the past 2 years, new drugs have been approved by the FDA that appear to actually modify the progression of the disease. On this webcast, we’re going to update you on Alzheimer’s Disease. Joining us is Assistant Professor of Neurology, Dr. Arun Ramamurthy.

What you’ll learn on this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe Alzheimer’s Disease pathology
  • Discuss current medication options
  • Highlight Alzheimer’s Biomarkers
  • Future directions in diagnosis and treatment

You’ll also learn about the following:

  • Diagnosis of Alzheimer’s Disease
  • Treatment of Alzheimer’s Disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.